Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06694012
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:27:05.488144+00:00
Published At
2024-12-04T00:00:00+00:00
Record Updated At
2024-12-04
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Type 2 Diabetes Mellitus (T2DM)", "Type 2 Diabetes", "Diabetes Mellitus", "Hypertension", "Hyperglycemia", "Hyperlipidemia", "Dyslipidemia", "Hyperuricemia or Gout", "Hyperuricemia, Gout", "Obesity", "Obesity/Epidemiology", "Obesity, Abdominal", "Central Obesity", "Visceral Fat", "Chronic Kidney Disease(CKD)", "Atherosclerosis", "Metabolic Syndrome", "Hepatic Steatosis", "Insulin Sensitivity/Resistance"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-12-04"
protocolSection.identificationModule.nctId
"NCT06694012"
protocolSection.identificationModule.officialTitle
"Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Type 2 Diabetes Mellitus (T2DM) (protocolSection.conditionsModule.conditions)
  • Type 2 Diabetes (protocolSection.conditionsModule.conditions)
  • Diabetes Mellitus (protocolSection.conditionsModule.conditions)
  • Hypertension (protocolSection.conditionsModule.conditions)
  • Hyperglycemia (protocolSection.conditionsModule.conditions)
  • Hyperlipidemia (protocolSection.conditionsModule.conditions)
  • Dyslipidemia (protocolSection.conditionsModule.conditions)
  • Hyperuricemia or Gout (protocolSection.conditionsModule.conditions)
  • Hyperuricemia, Gout (protocolSection.conditionsModule.conditions)
  • Obesity (protocolSection.conditionsModule.conditions)
  • Obesity/Epidemiology (protocolSection.conditionsModule.conditions)
  • Obesity, Abdominal (protocolSection.conditionsModule.conditions)
  • Central Obesity (protocolSection.conditionsModule.conditions)
  • Visceral Fat (protocolSection.conditionsModule.conditions)
  • Chronic Kidney Disease(CKD) (protocolSection.conditionsModule.conditions)
  • Atherosclerosis (protocolSection.conditionsModule.conditions)
  • Metabolic Syndrome (protocolSection.conditionsModule.conditions)
  • Hepatic Steatosis (protocolSection.conditionsModule.conditions)
  • Insulin Sensitivity/Resistance (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.